Interventions for the treatment of Paget's disease of the vulva.
CONCLUSIONS: Since the last version of the review was published there are many more cases in the literature reporting a clinical response to 5% imiquimod cream. There is one prospective study of eight women treated with 5% imiquimod for recurrent Paget's disease of the vulva, and one prospective trial of 20 women was due to be reported. This increasing evidence for the safety and efficacy of 5% imiquimod will be helpful for women and clinicians alike. Ideally, a multicentre RCT of reasonable size is needed, but ongoing publications of high-quality non-randomised prospective studies will enhance the current available literature.
PMID: 31167037 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Edey KA, Allan E, Murdoch JB, Cooper S, Bryant A Tags: Cochrane Database Syst Rev Source Type: research
More News: Anatomy | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Databases & Libraries | General Medicine | Laser Surgery | Laser Therapy | Paget's Disease | Rare Diseases | Skin | Skin Cancer | Study | Women